Clinical Trial Details
EORTC-22863
Back to Clinical Trials Database
Phase III randomized clinical trial in high metastatic risk carcinoma of the prostate comparing pelvic radiotherapy plus LHRH analogue (Jointly with the EORTC Genito-Urinary Cancers Group)
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 01-May-1987 Date Step1 close: 20-Nov-1995 |
Data management at EORTC | Yes |
Design |
Phase 3 Randomized open label |
Targeted Sample size | EORTC Groups: 300 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT00849082 |
NCT number | NCT00849082 |